(Total Views: 159)
Posted On: 01/14/2022 2:50:52 PM
Post# of 15424
$ABBV News Article - U.S. FDA Approves RINVOQ (upadacitinib) to Treat Adults and Children 12 Years and Older with Refractory, Moderate to Severe Atopic Dermatitis https://marketwirenews.com/news-releases/u-s-...98276.html
(0)
(0)
My Twitter: WhyteStocks
